AptarGroup, Inc.
Thesis
AptarGroup is a market leader in packaging solutions across pharma, beauty, and food sectors, with a strong growth outlook driven by its shift towards the higher-margin pharma segment. The company is expected to achieve mid-high single digit revenue growth and margin expansion, particularly as it capitalizes on trends in respiratory diseases and injectable devices. The target price of $167.42 reflects a CAGR of 9.4%, indicating solid long-term value.
Did it work?
The stock price has decreased by 1.0% over 28 months, which contradicts the long thesis that anticipated mid-high single digit revenue growth and margin expansion. Given that the target price of $167.42 implied a CAGR of 9.4%, the actual performance does not align with the expected growth trajectory, indicating that the thesis did not materialize as projected.
Raw excerpt
No raw excerpt stored.